ArticleAmerican journal of translational research2024
Risk factors in immune-related recurrent spontaneous abortion and construction of predictive models.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo explore the risk factors associated with immune-related recurrent spontaneous abortion (IRSA) and to develop a predictive model to identify high-risk individuals, aiming to provide theoretical guidance for RSA prevention.
methodsThis retrospective study included 120 patients with RSA who were treated at Jiangxi University of Traditional Chinese Medicine Hospital between January 2022 and January 2024. Patients were divided into two groups based on the nature of their miscarriages: the IRSA group (observation group, n=58) and the non-IRSA group (control group, n=62). Univariate and multivariate analyses were conducted to identify independent risk factors for IRSA. Using these factors, a nomogram prediction model was constructed and validated with R software (version 4.1.2).
resultsIndependent prognostic factors for immune-related RSA included average platelet aggregation rate (95% CI 1.005-4.387; P=0.027), hemoglobin (95% CI 0.856-6.205; P=0.014), antiphospholipid antibodies (95% CI 0.954-5.465; P=0.024), triglycerides (TG) (95% CI 1.009-8.369; P=0.016), and free triiodothyronine (FT3) (95% CI 1.236-7.069; P=0.026). Using these factors, a nomogram was developed for predicting immune-related RSA incidence. The model achieved an AUC of 0.7975882 (95% CI 0.635-0.947), indicating good predictive accuracy, and decision curve analysis demonstrated positive net benefits.
conclusionFT3, TG, antiphospholipid antibodies, hemoglobin, and average platelet aggregation rate are independent risk factors for IRSA onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.